Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Yael L. Maxwell

December 13, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

Caitlin E. Cox

November 16, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Presentation TCT 2024

TCT 1505: Trans-Femoral TAVR in an End-Stage Liver Disease Patient With Severe Aortic Regurgitation due to Infective Endocarditis

Presenter: Joshua Zuniga

October 30, 2024

Presentation TCT 2024

Regurgitant Fraction Quantified by Liver Mapping Analysis Using Cardiac Magnetic Resonance Predict Outcomes in a Large Cohort of All-Comers Patients with Chronic Tricuspid Regurgitation

Presenter: Davide Margonato

October 28, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Appropriate Use Criteria Advise on Multimodality Imaging Before Noncardiac Surgery

Yael L. Maxwell

August 27, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

Registry Data Reassure on Safety With Next-Generation Watchman Device

L.A. McKeown

July 30, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Daily News

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

L.A. McKeown

June 12, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

Advertisement

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

TCT 1505: Trans-Femoral TAVR in an End-Stage Liver Disease Patient With Severe Aortic Regurgitation due to Infective Endocarditis

Regurgitant Fraction Quantified by Liver Mapping Analysis Using Cardiac Magnetic Resonance Predict Outcomes in a Large Cohort of All-Comers Patients with Chronic Tricuspid Regurgitation

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Will Semaglutide Change Cardiac Surgery? It Already Has

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Appropriate Use Criteria Advise on Multimodality Imaging Before Noncardiac Surgery

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Registry Data Reassure on Safety With Next-Generation Watchman Device

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Statins Effective For Primary Prevention in Old and Very Old

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content